Mirion Technologies falls 8% despite beating Q2 estimates

Published 31/07/2025, 23:00
Mirion Technologies falls 8% despite beating Q2 estimates

Investing.com -- Mirion Technologies Inc (NYSE:MIR), a provider of radiation detection and monitoring solutions, saw its shares tumble 8% despite reporting second-quarter results that exceeded analyst expectations, as investors appeared concerned about revised organic growth guidance.

The company reported adjusted earnings per share of $0.11 for the second quarter ended June 30, 2025, beating the analyst estimate of $0.10. Revenue rose 7.6% YoY to $222.9 million, surpassing the consensus estimate of $217.04 million. The company swung to a GAAP net income of $8.5 million, a 171% improvement from a GAAP net loss of $12.0 million in the same period last year.

Despite the positive quarterly results, Mirion’s stock dropped sharply as the company revised its organic revenue growth guidance to 5.0%-7.0% from the previous 5.5%-7.5%, citing reductions in Labs & Research and Dosimetry end-markets expectations, which more than offset increased growth in the Nuclear Power segment.

"Our second quarter results demonstrate continued progress towards key 2025 financial targets and positively position us to capture robust market dynamics," said Thomas Logan, Mirion’s Chairman and Chief Executive Officer. "Nuclear power and cancer care tailwinds remain vibrant and Mirion is better positioned than ever to capitalize on these favorable market trends."

The company raised its full-year 2025 guidance for total revenue growth to 7.0%-9.0% from 5.0%-7.0% previously, and increased its adjusted EBITDA forecast to $223-$233 million from $215-$230 million. Mirion also boosted its adjusted EPS guidance to $0.48-$0.52, compared to the analyst consensus of $0.49.

During the quarter, Mirion completed a $400 million convertible notes offering, refinanced its Term Loan B, and announced the acquisition of Certrec to expand its services and software offerings in the nuclear power market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.